People news

Share this article:
Contract sales firm PDI has appointed Richard Micali to senior vice president of sales services, effective immediately. Micali most recently served as vice president, sales, at Bristol-Myers Squibb, and led BMS's US national sales force on Eribitux, a biologic cancer product.
 
Biopharma Gilead Sciences has announced the promotion of Andrew Cheng to the newly created role of senior vice president, development operations. Cheng will join Gilead's executive committee, and will report to Norbert Bischofberger, EVP Research and Development, and chief scientific officer.
 
Merck appointed D. Gary Gilliland, a cancer scientist and researcher at Harvard, to SVP of Merck Research Laboratories (MRL), and head of the company's oncology franchise. Gilliland will begin his role with Merck on March 2, reporting to Peter Kim, president of MRL. 
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in People Moves

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media